SBC Medical Inc

SBC

Latest QuantConomy context for SBC: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for SBC. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for SBC

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
fundamental eps change	very bearish	76	May 14, 12:00 AM	SBC (Q1 2026, diluted eps): EPS declined 78.0% ($0.50 → $0.11). [sequential period basis, very bearish signal]
fundamental revenue change	very bearish	76	May 14, 12:00 AM	SBC (Q1 2026, revenue): declined 76.1% ($158.86M → $37.96M). [sequential period basis, very bearish signal]
fundamental operating income change	very bearish	76	May 14, 12:00 AM	SBC (Q1 2026, operating income): declined 73.7% ($67.49M → $17.72M). [sequential period basis, very bearish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
SBC	NASDAQ	alpaca	SBC Medical Group Holdings Incorporated Common Stock
SBC	NASDAQ	fmp	SBC Medical Group Holdings Incorporated
SBC	NASDAQ	alphavantage	SBC Medical Group Holdings Inc

Buys, last 90d

Sells, last 90d

Rows

No recent Form 3, 4, or 5 insider transaction rows were returned for SBC.

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.